hiv and tuberculosis hesi case study quizlet

High School
You don't have any recent items yet.
You don't have any courses yet.
You don't have any books yet.
You don't have any Studylists yet.
Information

HESI Case Study Playerhiv

Med surg (nur201), fortis college, recommended for you, students also viewed.

C57 - ch 57 test bank
C56 - ch 57 test bank
C35 - ch 35 test bank
C34 - ch 34 test bank
C31 - ch 31 test bank
C30 - ch 30 test bank

Preview text

2/16/23, 7:19 PM HESI | Case Study Player

hesi-preparation-suite.elsevier/#/content-player?assessmentVtwId=case_cc5e9b51-af96-463f-abce-aae7604f69dc&instanceId=bundle_26... 1/

Immunodeficiency

Virus (hiv) and, tuberculosis (tb).

Case Study | 54mins

Meet the Client Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Section 7 Section 8 Section 9 Section 10 Section 11 Section 12 Section 13 Section 14 Post Result

Post Result

100% Correct

Let's review your results from 2/16/2023 at 7: pm EST

Question 1 of 26

How should the PN respond to Matthew’s

Begin Again

Correct Incorrect

Matthew is requesting an opportunity for psychosocial support, which should be honored by the PN if possible.

Remind the client that his priority is to get plenty of rest, rather than to socialize.

Significant others who have been in close proximity to the client may stay in the room, but there is a better method to reduce the risk of disease transmission.

Instruct the client that his partner can stay, but only after the PN receives the results of his partner's tuberculin skin test.

Advise the client that his partner may visit but will need to follow the hospital’s required airborne isolation precautions.

Multiple Choice

Course : Med Surg (NUR201)

University : fortis college.

hiv and tuberculosis hesi case study quizlet

More from: Med Surg NUR201 Fortis College 616 Documents Go to course

Human immunodeficiency virus infection and tuberculosis: an analysis and a course of action

Affiliation.

1 Cornell University Medical College, New York, NY 10021.
PMID: 8069273
PMCID: PMC2359193

Tuberculosis, once on the steady decline in the western world, has resurfaced with renewed vigor in the wake of the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) epidemic. People with HIV infection are both more likely to contract primary tuberculosis and at greater risk for reactivation of latent tuberculosis. Tuberculous disease may present with atypical signs and symptoms in HIV-infected hosts because of alterations in the immune system. Superimposed on the virulent interaction of HIV and tuberculosis is the emerging problem of multidrug resistant strains that often resist currently available therapies. HIV-positive health professionals working in high-risk environments pose a special problem, while populations unable to comply with currently available pharmacological therapies pose another. We have many tools available to combat the resurgence of tuberculosis, but new methods of diagnosis and new approaches to treatment are sorely needed.